TMTigran B. Melik-Kasumov

Tigran B. Melik-Kasumov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tigran B. Melik-Kasumov has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • PPARα activation with fenofibrate confers hippocampal neuroprotection but lacks disease-modifying efficacy in chronic temporal lobe epilepsy

    by Olga E. Zubareva, Tigran B. Melik-Kasumov, Denis S. Sinyak, Gleb S. Velikoborets, Anna A. Kovalenko, Alesya A. Zhabinskaya, Stepan A. Kolyhan, Marina A. Korneeva, Maria V. Zakharova, Aleksey V. Zaitsev

  • Open Access

    Age-related features of the intestinal microbiota changes in Wistar rat pups after application of antibiotics and prebiotic 2′-fucosyllactose

    by A. A. Zhabinskaya, T. B. Melik-Kasumov, H. E. Pyzh

    The gut microbiota plays an important role in the formation of the body’s regulatory systems (nervous, endocrine, immune), which is especially important at an early age. Hence, gut dysbiosis can lead to an impaired development of both the intestinal microbiota and these regulatory systems. Prebiotics can have a positive effect on the development of the intestinal microbiome, which can correct negative changes.The aim of this study is to investigate the features of development of antibiotic-associated dysbiosis in the early postnatal period in rats and to evaluate the effect of 2′-fucosyllactose in health and during dysbiosis.The study was conducted on Wistar rats aged 12–26 days. To develop dysbiosis at an early age, the following mixtures were used: a mixture of ampicillin trihydrate 75 mg/kg and metronidazole 50 mg/kg and a mixture of amoxicillin 30 mg/kg and cephalexin 20 mg/kg for three days, starting on the 12th day of life. As a prebiotic 2′-fucosyllactose at a dose of 1 g/kg was used, starting on the 12th day and to the last experiment day.In healthy animals, there is a decrease in the gut content of Bifidobacterium spp. and Enterococcus spp. at the age of 26 days. A mixture of ampicillin trihydrate 75 mg/kg and metronidazole 50 mg/kg leads to gut dysbiosis – growth suppression of bifidobacteria, lactobacilli and enterococci. After the end of antibiotics application and continued lactation, the titer of the described bacteria is restored. 2′-fucosyllactose has an effect on the preservation of the titer of Bifidobacterium spp. and Enterococcus spp., both in healthy animals and after early dysbiosis.Our results indicate that antibiotic-associated dysbiosis at an early age is characterized by a temporary but powerful effect. At the same time, the use of 2′-fucosyllactose leads to preserving important probiotic groups of intestinal bacteria, both in health and after dysbiosis.

  • Open Access

    Beneficial Effects of Probiotic Bifidobacterium longum in a Lithium–Pilocarpine Model of Temporal Lobe Epilepsy in Rats

    by Olga E. Zubareva, Alexandra V. Dyomina, Anna A. Kovalenko, Anna I. Roginskaya, Tigran B. Melik-Kasumov, Marina A. Korneeva, Alesya V. Chuprina, Alesya A. Zhabinskaya, Stepan A. Kolyhan, Maria V. Zakharova, et al.

    Epilepsy is a challenging brain disorder that is often difficult to treat with conventional therapies. The gut microbiota has been shown to play an important role in the development of neuropsychiatric disorders, including epilepsy. In this study, the effects of Bifidobacterium longum, a probiotic, on inflammation, neuronal degeneration, and behavior are evaluated in a lithium–pilocarpine model of temporal lobe epilepsy (TLE) induced in young adult rats. B. longum was administered orally at a dose of 109 CFU/rat for 30 days after pilocarpine injection. The results show that B. longum treatment has beneficial effects on the TLE-induced changes in anxiety levels, neuronal death in the amygdala, and body weight recovery. In addition, B. longum increased the expression of anti-inflammatory and neuroprotective genes, such as Il1rn and Pparg. However, the probiotic had little effect on TLE-induced astrogliosis and microgliosis and did not reduce neuronal death in the hippocampus and temporal cortex. The study suggests that B. longum may have a beneficial effect on TLE and may provide valuable insights into the role of gut bacteria in epileptogenesis. In addition, the results show that B. longum may be a promising drug for the comprehensive treatment of epilepsy.


  • Neuroprotective Effect of Palmitoylethanolamide in the Lithium-Pilocarpine Model of Temporal Lobe Epilepsy

    by T. B. Melik-Kasumov, M. A. Korneyeva, A. V. Chuprina, A. A. Zhabinskaya, A. A. Rozhko

    Epilepsy is one of the most common chronic neurological diseases. About 30% of patients with epilepsy suffer from drug resistant forms of the disease. In this regard, a thorough investigation of the pathogenetic mechanisms of epilepsy, as well as a search for new anticonvulsant or neuroprotective compounds, are still relevant. Evaluation of the effects of endogenous compounds in experimental models of epilepsy can be useful for solving both of these problems. The aim of this study was to assess the neuroprotective effect of palmitoylethanolamide (PEA) in a lithium-pilocarpine model of temporal lobe epilepsy in Wistar rats at the age of 10–11 weeks. PEA was applied subcutaneously at a dose of 10 mg/kg one hour after the relief of status epilepticus (SE) and then at a daily basis for 7 days. The neuroprotective properties of PEA were assessed by changes in behavior in the open field test before SE and 20 days thereafter, as well as by changes in the neuronal density in the CA1 region and hilus of the dorsal and ventral hippocampus, and the degree of mossy fiber retrograde sprouting into the molecular layer of the dentate gyrus 21 days after SE. It was found that PEA administration during the first week after SE leads to a retention of some behavioral features of healthy animals, reduces the degree of neurodestruction in CA1 and the level of mossy fiber retrograde sprouting in both the dorsal and ventral hippocampus. Thus, the results of the study indicate a moderate neuroprotective effect of PEA in the model of temporal lobe epilepsy.


  • MODIFICATION OF THE EXPERIMENTAL MODEL OF ELECTRICALLY INDUCED SEIZURES IN ANIMALS

    by Iryna Alexandrovna Siamionik, Marina Alexandrovna Komeeva, Vladimir Sergeevich Terekhov, Anastasia Olegovna Parashchenko, Ekaterina Viktorovna Fiodarava, Tigran Melik-Kasumov, Svetlana Nikolaevna Rjabceva

    Новые препараты для лечения эпилепсии появляются достаточно редко, одной из причин является отсутствие воспроизводимых экспериментальных моделей различных типов приступов при эпилепсии. Актуальной задачей является разработка экспериментальных моделей конкретных эпилептических приступов. ЦЕЛЬ ИССЛЕДОВАНИЯ: адаптировать экспериментальную модель электрической стимуляции парциальных и генерализованных эпилептических приступов. МАТЕРИАЛЫ И МЕТОДЫ: экспериментальное исследование проведено на крысах линии Wistar (n=40). Первая группа (n=20) - животные, после имплантации внутримозгового электрода и электрической стимуляции парциальных эпилептических приступов; вторая группа (n=20) - животные с последующей стимуляцией генерализованных эпилептических приступов. Оценка развивающихся эпилептических приступов проводилась по пятибальной шкале Расина. РЕЗУЛЬТАТЫ. Проведена модификация и адаптация импульс-зависимой экспериментальной модели электрической стимуляции парциальных и генерализованных приступов: контролируя диапазон амплитуды импульса подаваемого тока (напряжение тока) в эксперименте, можно вызывать различные по характеру эпилептические приступы у подопытных животных. ЗАКЛЮЧЕНИЕ. модифицирована и отработана недорогая современная, хорошо воспроизводимая, импульс-зависимая модель формирования простых парциальных моторных приступов и генерализованных эпилептических приступов у...

  • Open Access

    ANTICONVULSANT EFFECT OF STEAROYLETHANOLAMINE IN THE MODEL OF EPILETIC SEIZURE

    by T. B. Melik-Kasumov, E. S. Shavalda, A. N. Batyan

    Целью настоящего исследования являлась оценка противосудорожного потенциала эндогенного липидного сигнального соединения – этаноламида стеариновой кислоты, или стеароилэтаноламина (SEA), – вещества, обладающего каннабимиметическим эффектом. В модели эпилептического припадка, вызванного инъекцией пентилентетразола (60 мг/кг), оценивали эффекты SEA в дозах 1 и 10 мг/кг. SEA вводили в смеси растворителей (спирт, полисорбат-80, физиологический раствор; 5:5:90 об. % соответственно), которая сама по себе не вызывала изменений во времени наступления или выраженности эпилептического припадка. Развитие припадков оценивали по шкале Расина. Установлено, что заблаговременная (за 30 мин) внутрибрюшинная инъекция SEA в дозе 1 мг/кг не вызывает достоверных изменений в формировании тонико-клонических припадков, вызванных пентилентетразолом. В то же время в дозе 10 мг/кг SEA увеличивает латентный период до наступления первого приступа на 58 %, а также снижает общую выраженность судорожной активности по шкале Расина на 27 %. Таким образом, SEA в дозе 10 мг/кг обладает противосудорожным действием, однако не подавляет судороги полностью. Механизмы обнаруженного действия стеароилэтаноламина нуждаются в дальнейшем уточнении.